2nd Annual Pediatric Brain Symposium is organized by Johns Hopkins All Children's Hospital and will be held from Nov 12 - 15, 2020 at The Westin Sarasota, Sarasota, Florida, United States of America. Both onsite and virtual conference registration options are available. The number of available onsite registrations is limited and available on a first come- first serve basis. Target Audience: Neurologists, Psychologists, Neuropsychologists, Development Specialists, Pediatricians, Medical Trainees, Nurses, and Advanced Practice Providers. Accreditation: Credit Designation Statement: The Johns Hopkins University School of Medicine designates this live activity for a maximum of ​13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Course Description: The 2nd Annual Pediatric Brain Symposium will provide valuable updates on current trends across a spectrum of disorders in the pediatric and adolescent brain. Featuring professionals in various fields of the neurosciences, this conference will address issues in pediatric brain health with a focus on epilepsy, headaches and autism. Interrelated specialists and practitioners will hear from nationally-recognized specialists while enjoying the beautiful setting of The Westin in Sarasota, Florida. Conference Highlights: • Choose One of Two Optional Pre-Conference Workshops: ○ Dynamic and Interactive Simulation on Common Pediatric Neurology Office Scenarios ○ Motivational Interviewing • Featuring Three Pecha Kucha Lectures • Onsite and Virtual Conference Registration Available Learning Objectives: After attending this activity, participants will demonstrate the ability to: • Identify signs and symptoms of autism in the primary care and specialist office. • Outline evidence-based treatment options for autism spectrum disorder. • Describe pharmacological treatments for autism spectrum disorders. • Discuss mechanisms in the transition from acute headache pain to chronic daily headache. • Identify medical and complimentary treatments for headaches. • Explain traditional treatment options for migraine headaches and recent advances in treatment. • Define pediatric epilepsy syndromes. • Review clinical assessment and diagnostic testing for an epilepsy diagnosis. • Explain traditional treatment options for epilepsy and recent advances in treatment.

Primary Care: Top Topics In Rheumatology And Geriatrics is organized by American Medical Seminars (AMS), Inc. and will be held from Jan 25 - 28, 2020 at The Westin Sarasota, Sarasota, Florida, United States of America. This Course has been approved for a maximum of 20 AMA PRA Category 1 Credits™. Description: All AMS 2020-2021 CME conferences are Live, Half-day, Commercial-Support Free and are approved for AMA PRA Category 1 Credits™. Additional accreditation information available on our website. All of our medical meetings are clinically useful evidence/case-based, guideline-driven, Primary Care content that is immediately applicable to your practice. All of our CME conferences, both live and recorded, can be found at www.AmericanMedicalSeminars.com. AMS CME meetings are held in both Sarasota, FL and San Diego, CA, and are designed for Primary Care Practitioners in the specialties of Family Medicine, Internal Medicine, Emergency Medicine, and even Specialists who would like practical and clinically relevant reviews and updates in Primary Care Medicine. Can’t attend our Live CME conferences? Check out our Self Study Travel CME courses on our website at www.AmericanMedicalSeminars.com. Additional details will be posted as soon as information is available.  

Pediatric Emergency Medicine: Emergent and Urgent Challenges is organized by American Medical Seminars (AMS), Inc. and will be held from Nov 02 - 05, 2020 at Lido Beach Resort, Sarasota, Florida, United States of America. This Course has been approved for a maximum of 20 AMA PRA Category 1 Credits™. Description: Day 1: Pediatric Emergency Radiology: Upon completion of this session, the participant should be able to: COMP • Assess the radiographic findings after case description. • Diagnose various pediatric conditions after case description and radiographic assessment. Judicious Use of Antibiotics in Outpatient Setting: Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP • Identify antibiotic prescribing patterns, outcomes, and expenditures for common pediatric conditions. • Differentiate between common pediatric infections and those that require antibiotic treatment. • Develop a clinical approach to the diagnosis and therapy of sinusitis. Articles That Change the Way We Practice Pediatric Emergency Medicine: Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP • Analyze the latest Emergency Medicine literature to bring improved care to the bedside. Fluid and Electrolyte Emergencies: Upon completion of this session, using AAP guidelines and evidence-based medicine, the participant should be able to: EBM, GL, COMP • Assess the degree of dehydration in children based on factors evaluated in recent published research. • Utilize oral rehydration and subcutaneous rehydration in appropriately selected pediatric patients. • Discuss the presentations and treatment of children with abnormalities in serum sodium and potassium concentrations. Dilemma of the Foreign Body - Aspirated or Ingested: Upon completion of this session, using evidence-based medicine, the participant should be able to: EBM, COMP • Distinguish the epidemiology and clinical presentation of aspirated versus ingested foreign bodies. • Analyze the rationale for radiographic evaluation of children with a history of foreign body ingestion. • Review the diagnostic approach and radiographic interpretation of children with aspirated foreign bodies. Day 2: Diagnosis and Misdiagnosis of Appendicitis in Childhood: Upon completion of this session, using evidence-based medicine, the participant should be able to: EBM COMP • Review the pathophysiology of appendicitis. • Associate the pathophysiology of appendicitis with the signs and symptoms. • Analyze various diagnostic approaches to appendicitis in childhood. • Criticize the care provided in several cases of appendicitis missed at the time of initial ED evaluation. Medical Errors in Pediatrics: Upon completion of this session, the participant should be able to: EBM COMP • Demonstrate root cause analysis and perform it on cases of medical errors that involve children. • Assess specific, evidence-based risks for medication errors and strategies to reduce their occurrence. • Review issues in sleep physiology that relate to medical error risks, and make evidence-based recommendations for sleep management. The Septic Appearing Infant: Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP • Conclude that an infectious etiology is not the only cause of a “toxic” appearing child. • Differentiate neurologic, hematologic, toxin, and cardiac causes of the ill child. Orthopedic Conditions Above the Hip: Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP • Interpret radiographs that demonstrate Salter-Harris fractures in the pediatric patient. • Initially manage fractures of the upper extremity and recognize when to refer to an Orthopedic Surgeon. • Develop management plans for fractures; assess the need for urgent orthopedic consultation. Pediatric Poisonings: Upon completion of this session, using AAP guidelines and evidence-based medicine, the participant should be able to: EBM, GL, COMP Review data on pediatric poisonings including recent trends. • Employ appropriate gastrointestinal decontamination in a variety of pediatric ingestions. • Discuss management of several specific poisonings. Day 3: Life-Threatening Pediatric Infections: Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP • Conclude that as newer immunizations eradicate many serious infections, we are still faced with certain pathogens that can cause severe morbidity and mortality. • Recognize, diagnose and manage the following diseases: • Toxic Shock Syndrome; • Meningococcemia; • Rocky Mountain Spotted Fever; • Kawasaki • Develop an approach to the patient who presents with fever and a rash. Upper Airway Emergencies in the Pediatric Patient: Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP • Recommend medication therapy for selected upper airway emergencies. • Interpret the most recent evidence-based literature in the approach to the child with croup. • Distinguish and discriminate among the varied presentations of pediatric stridor. Non-Traumatic Surgical Abdominal Emergencies: Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP • Recognize pediatric abdominal processes that require surgical intervention. • Formulate and prepare initial emergency room management of specific abdominal surgical emergencies. Approach to Febrile Infants and Toddler: Upon completion of this session, using published guidelines and evidence-based medicine, the participant should be able to: EBM, GL, COMP • Assess the risks of various management strategies of febrile infants less than 2 months of age. • Appraise recent data concerning the clinical approach to febrile young infants. • Appraise data concerning the diagnostic evaluation of febrile children 3-24 months of age. • Recognize the changing epidemiology of invasive bacterial infections secondary to widespread vaccination practices. Acute Management of Childhood Asthma: Upon completion of this session, using published practice guidelines and Cochrane EBM sources, the participant should be able to: EBM, GL, COMP • Determine the appropriate use of albuterol by metered-dose inhaler, intermittent nebulizer, and continuous nebulizer for children with moderate and severe asthma exacerbations. • Appropriately apply the evidence regarding levalbuterol as compared with albuterol in the treatment of childhood asthma. • Employ recent data and recommendations for the use of steroids, magnesium sulfate, terbutaline, and ipratropium bromide in the treatment of acute asthma exacerbations. • Recognize indications for inpatient hospitalization in children with acute asthma exacerbations. Day 4: Pediatric Seizures I. Status Epilepticus, II. Febrile Seizures: Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP • Demonstrate appropriate medications to treat pediatric status epilepticus. • Utilize the literature concerning epidemiology of febrile seizures in educating patients’ families. Head Injuries in the Pediatric Patient: Upon completion of this session, using evidence-based medicine and guidelines from the 4th International Symposium on Concussion in Sport, the participants should be able to: EBM, GL, COMP • Describe the pathophysiology and, using evidence-based medicine, develop clinical strategies for the emergency treatment of severe head injury in childhood. • Apply an evidence-based medicine approach to decisions regarding obtaining a CT scan in children after minor head trauma. • Recognize the signs and symptoms of concussions in pediatric patients. • Demonstrate use of currently recommended management approaches in children with concussion. Blunt Abdominal Trauma in Children: Upon completion of this session, using evidence-based medicine and published guidelines, the participant should be able to: EBM, GL, COMP • Recognize injury mechanisms and clinical findings that are characteristic of solid organ injury and hollow viscus injury in children. • Integrate the role of various laboratory and radiologic tests in the diagnosis of solid organ injury and hollow viscus injury in children. • Develop and employ appropriate management strategies for children with significant intra-abdominal injuries. • Appraise recent data regarding the utility of focused abdominal sonography in trauma (FAST) in pediatric trauma. The Child with a Limp: Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP • Discuss the importance of age to specific hip pathology. • Differentiate etiologies of limp in the pediatric patient. • Review management of specific orthopedic conditions. Visual Diagnosis: You Make the Call: Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP • “Make the correct call” on slides representing interesting physical examination findings of pediatric patients. • Evaluate the visual presentation of over 25 different conditions to determine the DDx, lab, imaging and/or their respective treatments or referral as indicated. Some conditions to be covered include: • Testicular Torsion • Herpes Zoster • Periorbital Cellulitis • Mastoiditis • Erythema Multiforme (Minor) • Pre-Auricular Adenitis • Lap-Belt Complex • Hematuria

Primary Care Challenges in Endocrinology, Internal Medicine and Hospital Medicine is organized by American Medical Seminars (AMS), Inc. and will be held from Nov 09 - 12, 2020 at Lido Beach Resort, Sarasota, Florida, United States of America. Accreditation: • 20 AMA PRA Category 1 Credits™ • 20 AAFP Credits • 20 ACEP Credits Description: Day 1: Adrenal Insufficiency- Primary and Secondary: Upon completion of this session, using evidence-based medicine and clinical practice guidelines, to include Endocrine Society Guidelines, the participant should be able to: COMP • Apply principles learned to evaluate the diagnostic tests used to confirm the diagnosis or primary or secondary adrenal insufficiency. • Employ therapeutic options for patients including pregnant patients with primary or secondary adrenal insufficiency. Thyroid Case Studies: Upon completion of this session, using evidence-based medicine and clinical practice guidelines, to include the American Thyroid Association Guidelines, the participant should be able to: COMP • Appreciate the role of a diagnostic thyroid scan or ultrasound. • Evaluate a patient for hyperthyroidism. • Prescribe therapeutic options for patients diagnosed with hypothyroidism. Systolic and Diastolic Heart Failure. Upon completion of this session, the participant should be able to: EBM, GL, COMP • Appropriately manage decompensated heart failure in hospitalized patients. • Assess the indications for positive inotropic agents and ultrafiltration in systolic heart failure. • Distinguish the treatment of systolic versus diastolic heart failure, as per the 2013 ACCF/AHA Guidelines for heart failure management. Atrial Fibrillation in the Hospitalized Patient: Upon completion of this session, the participant should be able to: GL, COMP • Assess and evaluate treatment options for atrial fibrillation with rapid ventricular response, as per the 2010 HFSA Guidelines. • Employ appropriate anticoagulation strategies for atrial fibrillation. • Distinguish the advantages of rhythm versus rate control treatment strategies, 2014 ACC/AHA Guidelines for atrial fibrillation management. • Determine the possible underlying causes of CHF exacerbations. Male Hypogonadism: Upon completion of this session, using evidence-based medicine from the JCEM, NEJM and others, the participant should be able to: COMP • Outline the classic causes of male hypogonadism. • Appreciate the entity of adult onset hypogonadism. • Describe the risks and benefits of testosterone use and apply toward decision making when reviewing treatment options. Day 2: Disorders of Calcium Metabolism: Upon completion of this session, using evidence-based medicine from the JCEM, Annual of IM and others, the participant should be able to: COMP • Outline the causes of hypercalcemia. • Recommend diagnostic testing for hyperparathyroidism. • Recognize secondary hyperparathyroidism. • Determine appropriate need for surgical intervention using clinical practice guidelines for asymptomatic hyperparathyroidism. Update in Perioperative Medicine: Upon completion of this session, the participant should be able to: EBM, GL, COMP • Appraise pre-operative cardiac risk stratification and management strategies, as per the ACC/AHA Risk Clinical Predictors. • Determine the role of non-invasive stress testing, echocardiography, coronary angiography and the use of biomarkers to assess peri-operative cardiac risk, as per the ACC/AHA (2014) Perioperative CV Evaluation Guidelines. • Relate the indications for beta blockers, statins and aspirin in the peri-operative period. • Evaluate the bleeding risks of commonly prescribed medications and OTC supplements taken pre-operatively. Challenging Infections: MRSA and C. difficile: Upon completion of this session, the participant should be able to: GL, COMP • Assess and apply appropriate treatment strategies for different types of methicillin resistant staph aureus infections. • Employ rational use and relate the precautions of newer antibiotics when treating resistant bacteria. • Distinguish Guideline based treatment of Clostridium difficile Polycystic Ovary Syndrome: Upon completion of this session, using evidence-based medicine and clinical practice guidelines, to include Rotterdam Guidelines, the participant should be able to: COMP • Recognize the distinguishing features of PCOS. • Prescribe appropriate laboratory tests to evaluate women with hirsutism. • Describe the non-reproductive aspects of PCOS. Cushing’s Syndrome and other Functional Disorders of the Adrenal: Upon completion of this session, using evidence-based medicine and clinical practice guidelines, to include Endocrine Society Practice guidelines, the participant should be able to: COMP • Outline the etiology of Cushing’s syndrome. • Evaluate a patient with an adrenal tumor. • Evaluate a patient for suspected hyperaldosteronism. To employ strategies to appropriately diagnosis and manage patients with pheochromocytoma. Day 3: Outpatient Anticoagulation Issues, Part 1: Upon completion of this session, the participant should be able to: GL, EBM, COMP • Manage outpatients on warfarin using current CHEST guidelines and The Joint Commission 2016 National Patient Safety Goals. • Determine factors leading to alterations in the international normalized ratio (INR). • Advise patients on the appropriate choice, duration, and intensity of anticoagulation in a variety of clinical scenarios. • Develop a familiarity with the new oral anticoagulants. Outpatient Anticoagulation Issues, Part 2:  Upon completion of this session, the participant should be able to: EBM, COMP • Develop an evidence-based approach on perioperative management of antithrombotic and anticoagulant medications. • Recognize the proper use of IVC filters using evidence-based medicine. • Develop a practical approach when transitioning patients on and off anticoagulants or switching between anticoagulants. • Identify appropriate use of anticoagulant and antithrombic medications in combined therapy. Practical Approach to the Patient with Hypertension: Upon completion of this session, using multiple research trials as well as the current JNC recommendations, the participant should be able to: GL, COMP • Apply the current JNC recommendations for treatment of hypertension. • Develop a rational approach to choosing medication in treating hypertension. • Decide when and how to evaluate for secondary causes of hypertension. Practical Approach to the Patient with Potential DVT: Upon completion of this session, using multiple research trials as well as applying recommendations from the ACCP, AAFP/ACP, and the AHA/ACC, the participant should be able to:: GL, COMP • Obtain an appropriate medical history to better identify those patients at risk. • More confidently evaluate and assess the patient suspected of having DVT. • Better manage patients with the confirmed diagnosis of DVT. Practical Approach to the Patient with Headache: Upon completion of this session, while applying recommendations from the IHC, NHF, AAFP, AAN and ACP, the participant should be able to: GL, COMP • Review the differential diagnosis of a patient presenting with the complaint of headache. • More confidently evaluate the patient with headache and appreciate the indications for imaging. • Develop a treatment plan that considers lifestyle changes as well as medications. Day 4: Practical Approach to the Patient with Diabetes: Upon completion of this session, using multiple research trials as well as recommendations from the ADA, EASN, AGA, CDA, AACE, ACP, and the AAFP, the participant should be able to: GL, COMP • Consider this primer on management. • Distinguish the patient who is likely to go on to develop complications and appreciate the potential long-term course. • Apply the current guidelines for therapy and access the anticipated outcome goals. Non-Surgical Approaches to the Patient with Obesity: Upon completion of these sessions, using multiple research trials as well as applying recommendations from the AGA, NIH – NHLBI, ACP, AHA, ASBS, and ACS, the participant should be able to: GL, COMP • Review the current popular diets available and marketed to your patients. • Take into consideration unique needs of the obese patient in order to create a comprehensive approach to the treatment of obesity. • Explain the basic physiology of obesity. • Manage the medications available for the treatment of obesity. Practical Approach to the Patient with Hyperlipidemia: Upon completion of this session, using multiple research trials as well as the recommendations of the NCEP, the participant should be able to:  • Apply the current NCEP guidelines. • Develop a practical approach for considering the new medications available. • Consider the new targets developed for cholesterol end point. Evaluation of the Patient with Syncope:  Upon completion of this session, the participant should be able to: GL, COMP • Appraise the various etiologies of syncope. • Use clues in the history and physical as well as simple office testing to risk stratify patients with syncope. • Develop a plan for appropriate use of additional testing in patients with syncope to include indications for EP testing as per the AHA Syncope Algorithm and the ESC Guidelines. • Assess the role of lifestyle measures, medication, and more invasive measures to prevent recurrent syncope.  Drug Interactions and Side Effects:  Upon completion of this session, the participant should be able to: GL, EBM, COMP • Determine the most common mechanisms for drug interactions. • Identify some of the most frequent culprit drugs such as Warfarin and Acetaminophen, AED’s, NSAIDs, and Statins. • Counsel patients regarding some of the most frequent side-effects seen with commonly used medications. • Employ The Joint Commission 2016 Ambulatory Care National Patient Safety Goals.

Family Medicine: An Evidence-Based Approach to Patient Care is organized by American Medical Seminars (AMS), Inc. and will be held from Nov 30 - Dec 03, 2020 at Lido Beach Resort, Sarasota, Florida, United States of America. This Course has been approved for a maximum of 20 AMA PRA Category 1 Credits™. Description: Day 1: Irritable Bowel Syndrome: Upon completion of this session, the participant should be able to: EBM, COMP • Appraise possible etiologies for Irritable Bowel Syndrome. • Select and utilize diagnostic criteria to identify IBS, based on the current medical evidence and expert recommendations. • Use the current medical literature to assess and screen for other conditions that can present with similar IBS symptoms. • Detect “red flag” signs and symptoms that should make one question the diagnosis of IBS. • Formulate an EBM diagnostic evaluation for patients with signs and symptoms of IBS. • Use the current medical literature to develop an EBM treatment plan for Irritable Bowel Syndrome. Dyspepsia: Upon completion of this session, the participant should be able to: EBM, COMP • Appraise symptoms and common etiologies for dyspepsia. • Use EBM to detect “alarm symptoms” that are suspicious for GI malignancy. • Apply current medical evidence and expert guidelines to construct a diagnostic evaluation for Dyspepsia. • Determine appropriate treatment for Dyspepsia based on current medical evidence and the likely etiology. Evaluation and Treatment of Hypertensive Patients: Upon completion of this session, using the most recent JNC Guidelines, the Cochrane Abstract Database and the evidence-based reports from Clinical Evidence, the participant should be able to: EBM, GL, COMP • Employ the non-pharmacologic treatment options to manage hypertension. • Specify the pharmacologic treatment options for patients with compelling indications based upon JNC Guidelines. • Formulate the therapeutic goal for controlling blood pressure in different patient populations and the combination of medications that can achieve that goal. • Distinguish the side effect risks for each class of antihypertensive medications.  Treating Patients with Type 2 Diabetes Mellitus: Upon completion of this session, using the American Diabetes Association, the European Association for the Study of Diabetes Guidelines and the Cochrane Abstract Database, the participant should be able to: EBM, GL, COMP • Evaluate the therapeutic goals in treating type 2 diabetes and their impact on morbidity and mortality. • Recommend the approach for choosing an oral hypoglycemic agent to treat type 2 diabetes. • Specify the clinical situations that would require the use of insulin to treat type 2 diabetes and the probable dosage form and average amounts required for control of A1c. • Develop the therapeutic options for preventing diabetic complications. Hyperlipidemia and CV Disease Prevention - A Review of the Literature and Recent AHA Guidelines: Upon completion of this session, the participant should be able to: EBM, GL, COMP • Create a diagnostic and treatment plan for patients based on the current evidence and AHA Guidelines. • Explain similarities and differences between the most recent and previous guidelines. • Identify areas of strength and weakness in the recent AHA Guidelines. • Utilize the most recent cholesterol guidelines at the point of care. Day 2: Carpal Tunnel Syndrome: Upon completion of this session, the participant should be able to: EBM, COMP • Apply an evidence-based approach to the identification of Carpal Tunnel Syndrome. • Detect clues that can help identify likely etiologies for Carpal Tunnel Syndrome. • Construct a differential diagnosis for Carpal Tunnel Syndrome. • Determine which patients would benefit from nerve conduction studies. • Discriminate the severity of Carpal Tunnel Syndrome. • Use EBM to select an appropriate treatment plan for Carpal Tunnel Syndrome Migraine Headaches - Update on Diagnosis and Treatment: Upon completion of this session, using the International Headache Society and U.S. Headache Consortium Guidelines and the National Guideline • Clearinghouse and the evidence-based reports from Clinical Evidence, the participant should be able to: EBM, GL, COMP • Construct the approach for evaluating a patient with possible migraine headaches. • Assess the advantages of supportive therapy and lifestyle changes in treating migraine headaches compared to pharmacologic therapy. • Appraise the pharmacologic options for treating the acute pain of a migraine headache. • Recommend a prophylactic therapy regimen for patients with recurrent migraine headaches. Chronic Obstructive Pulmonary Disease (COPD): Evaluation and Treatment: Upon completion of this session, using the ACCP GOLD guidelines, the AACVPR practice guidelines and the evidence-based reports from • Clinical Evidence, the participant should be able to: EBM, GL, COMP • Analyze the role of cigarette smoking in the etiology and natural history of COPD. • Formulate a treatment plan for the stages of COPD. • Recommend the follow-up required to assess the therapeutic efficacy of the treatment options. Evaluation and Treatment of Respiratory Infections Commonly Seen in Primary Care: Upon completion of this session, the participant should be able to: EBM, COMP • Formulate appropriate evaluation strategies for patients who present with respiratory conditions. • Identify history and exam findings that help differentiate common respiratory conditions. • Determine situations when antibiotics are appropriate for the treatment sinus infections. • Utilize severity index tools in the evaluation of pneumonia. • Utilize EBM to determine appropriate treatment for common respiratory conditions. • Discuss some of the controversies in the treatment of common respiratory infections seen in primary care.  Dementia: Upon completion of this session, the participant should be able to: EBM, GL, COMP • Detect symptoms consistent with the diagnosis of dementia. • Distinguish dementia from treatable conditions that have similar presentations. • Construct a diagnostic plan utilizing EBM and Expert Guidelines. • Differentiate the common Dementia syndromes and distinguish the characteristics between them. • Use EBM to design a treatment plan for dementia. Day 3: Delirium in the Elderly - Current Concepts: Upon completion of this session, the participant should be able to: EBM, COMP • Specify diagnostic features and common causes of delirium in seniors. • Distinguish the causes of persistent delirium. • Use evidence based medicine to formulate treatment approaches to delirious seniors. • Recognize treatment options for intermittent agitation using evidence based medicine. Geriatric Depression: Advances in Diagnosis and Treatment: Upon completion of this session, the participant should be able to: EBM, COMP • Differentiate the variety of clinical presentations of depressive disorders in seniors. • Appraise the utility of, and plan to use, the Geriatric Depression Scale. • Apply an evidence based approach to antidepressant drug therapy in seniors. • Apply the evidence based recommendations for use of non-drug antidepressant therapy. Adult Health Screening and Immunizations - Evidence-Based Approach: Upon completion of this session, using the USPSTF and Cochrane Abstract Database, the participant should be able to: EBM, GL, COMP • Apply the evidence-based recommendations for preventive screening tests for adults. • Determine the immunizations required for adults. • Appraise the side effects of adult immunizations. • Select the contraindications for each adult immunization and their alternative therapy. • Plan when screening tests can be discontinued in adults. Venous Thromboembolism (VTE): Diagnosis and Treatment: Upon completion of this session, using the ACCP and ATS Guidelines and the Cochrane Abstract Database, the participant should be able to: EBM, GL, COMP • Determine the diagnostic testing for evaluating a patient for possible VTE. • Apply the algorithm for diagnosing a pulmonary embolism in multiple clinical settings. • Differentiate the advantages and disadvantages of outpatient treatment compared to inpatient treatment for venous thromboembolism (VTE). • Order the frequency of monitoring and the adjustments needed for warfarin therapy in the treatment of VTE. A Practical Approach to Falls and Urinary Incontinence in the Elderly: Upon completion of this session, the participant should be able to: EBM, GL, COMP • Integrate the concept of multifactorial causes underlying falls and employ the American Geriatrics Society Guidelines for the Prevention of Falls and urinary incontinence in seniors. • Develop a full assessment approach to evaluate different causes, using detailed physical examination and functional performance evaluations. • Differentiate the effects of normal aging from pathologic processes and adverse drug effects as risk factors for falls and incontinence. • Apply NIH guidelines to formulate a preventative and therapeutic plan of care. Day 4: Vitamin B-12 and Vitamin D in Seniors: Upon completion of this session, the participant should be able to: EBM, COMP • Integrate the normal physiology of Vitamins B-12 and D. • Differentiate the pathologic syndromes associated with B-12 and D deficiency. • Develop an evidence based evaluation of B-12 and D deficiency for seniors. • Develop an evidence based approach to treatment options for B-12 and D in seniors. Advanced Nutritional Assessment and Therapy: Upon completion of this session, the participant should be able to: EBM, COMP • Integrate readily available clinical data to make accurate nutritional assessments in seniors. • Relate metabolic changes in aging to assess risk for malnutrition. • Apply an evidence based approach to treatment of undernutrition in seniors. Anemia - A Finding, Not Yet a Diagnosis: Upon completion of this session, using the Cochrane Abstract Database and AAFP Guidelines, the participant should be able to: GL, COMP • Distinguish the etiologies for the common anemias. • Construct the diagnostic evaluation to determine the etiology of each anemia. • Develop the therapeutic options for each identified anemia. • Formulate the appropriate follow-up evaluations for assessing the treatment efficacy. Osteoporosis: Treatment and Prevention: Upon completion of this session, using the USPSTF, NOF Guidelines and the Cochrane Abstract Database, the participant should be able to: EBM, GL, COMP • Debate the importance of the risk factors for an osteoporosis fracture. • Employ the diagnostic testing for patients at risk with osteoporosis. • Select the therapeutic medication to treat osteoporosis based upon the indications and side effects. • Assess the therapeutic role of repeating the DXA scan in patients treated for osteoporosis. Sensible Prescribing Practices for the Elderly: Upon completion of this session, the participant should be able to: EBM, COMP • Appraise and appreciate the limits of published trials studies on drug safety and efficacy for seniors. • Assess the subtle but significant drug side effects in the elderly. • Distinguish undesirable prescribing practices and employ better approaches based on current evidence-based referenced literature.

Neurology And Rheumatology: A Practical Approach to Complex Specialties is organized by American Medical Seminars (AMS), Inc. and will be held from Dec 07 - 10, 2020 at Lido Beach Resort, Sarasota, Florida, United States of America. This Course has been approved for a maximum of 20 AMA PRA Category 1 Credits™. Description: Day 1: Rheumatoid Arthritis.: Upon completion of this session, the participant should be able to: GL, COMP • Demonstrate the role of genetics, environmental factors, immune cells, and proinflammatory cytokines in the pathogenesis of rheumatoid arthritis. • Illustrate the clinical features, extra-articular manifestations, and complications of rheumatoid arthritis. • Utilize and compare various methods of measuring disease activity in rheumatoid arthritis. • Compare and contrast the mechanisms of action of current and emerging therapies for RA and prescribe treatment for patients with rheumatoid arthritis according to ACR guidelines. Rheumatologic Procedures: Upon completion of this session, the participant should be able to: GL, COMP • Use techniques for appropriate indications for intra-articular and soft tissue injections in rheumatology. • Employ appropriate pharmacologic and non-pharmacologic therapies including injections for painful joints as per the ACR recommendations and the various sited rheumatologic and META analysis studies. The Neurological Examination: Upon completion of this session, the participant should be able to: COMP,EBM • Organize the disparate parts of the neurologic examination into a personally relevant, manageable and reproducible diagnostic tool. • Perform a concise screening neurologic exam for asymptomatic patients. • Perform a problem-tailored neurologic exam for patients with neurologic complaints such as altered mental status and gait disturbances using evidence-based medicine. • Obtain maximum yield from the examination of a patient with an altered mental status. Multiple Sclerosis: Upon completion of this session, the participant should be able to: COMP,EBM • Recognize the typical clinical features of multiple sclerosis. • Initiate an appropriate series of diagnostic investigations. • Formulate an approach to abortive and prophylactic therapy of multiple sclerosis using evidence-based medicine. • Anticipate common medical complications of multiple sclerosis. Spondyloarthropathies: Upon completion of this session, the participant should be able to: EBM, COMP • Distinguish the clinical features of the different spondyloarthropathies to improve diagnostic accuracy. • Utilize clinical features, laboratory studies, and radiological studies to make a diagnosis of axial spondyloarthropathy. • Prescribe pharmacologic agents according to ACR and EULAR recommendations and evidence-based results from clinical trials for patients with spondyloarthropathies. Day 2: Seizures and Epilepsy - Diagnosis: Upon completion of this session, the participant should be able to: COMP,EBM • Differentiate among the major types of seizures. • Apply epidemiologic aspects to the diagnosis of epilepsy. • Employ AAN and AES practice guidelines regarding sudden unexpected death in epilepsy. (SUDEP) • Distinguish seizures from syncope. • Formulate a plan for diagnostic investigation. Seizures and Epilepsy - Management: Upon completion of this session, the participant should be able to: COMP,EBM • Determine when treatment with anticonvulsant medication is warranted using evidence-based medicine. • Choose among the many available anticonvulsant medications. • Manage problems confronted by women with epilepsy. • Counsel patients regarding their driving privileges. Osteoarthritis: Upon completion of this session, the participant should be able to: GL, COMP • Appraise the newer understandings of the pathophysiology of OA. • Distinguish the typical and atypical clinical features of OA. • Utilize the American College of Rheumatology guidelines for the treatment of OA of the hand, hip and knee. • Distinguish OA symptoms from those of other localized or generalized disorders. Septic Arthritis: Upon completion of this session, the participant should be able to: GL, EBM, COMP • Determine the risk factors associated with septic arthritis. • Utilize the British Society of Rheumatology Guidelines for management of the hot swollen joint in adults to differentiate septic arthritis from other causes of acute monoarticular arthritis. • Utilize epidemiological and clinical clues to determine bacterial etiology in patients with septic arthritis. Psychogenic Neurologic Disorders: Upon completion of this session, the participant should be able to: COMP • Evaluate common neurologic manifestations of psychogenic disorders. • Distinguish among malingering, factitious disorders and conversion disorders. • Conduct an interview of a patient with a suspected psychogenic disorder. • Formulate a plan for management of a psychogenic illness. Day 3: Lyme Disease and Other Topics in Rheumatology: Upon completion of this session, the participant should be able to: EBM, GL, COMP • Apply CDC and Infectious Diseases Society of America Guidelines for the diagnosis, treatment, and prevention of Lyme disease. • Evaluate skin rashes as manifestations of systemic diseases. • Using the Guidelines of the Bone Research Society of the United Kingdom to prescribe appropriate therapy for patients with Paget’s disease of the Bone. Idiopathic Inflammatory Myopathies: Upon completion of this session, the participant should be able to: GL, EBM, COMP • Distinguish the different inflammatory myopathies as outlined in the 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria. • Utilize clinical features and appropriate testing to make the diagnosis of inflammatory myopathies. • Illustrate the pharmacologic agents used according to ACR and EULAR recommendations based upon evidence-based results from clinical trials for patients with idiopathic inflammatory myopathy. Sleep Disorders - Insomnia and Obstructive Sleep Apnea: Upon completion of this session, the participant should be able to: COMP, EBM • Appraise the normal structure and function of stages of sleep. • Formulate a diagnostic and therapeutic approach to insomnia using best practice recommendations from the American Academy of Sleep Medicine and American Geriatric Society. • Detect clinical features and initiate management of sleep apnea. • Evaluate patients for comorbidities of obstructive sleep apnea. Sleep Disorders - Restless Legs Syndrome, Narcolepsy and Others: Upon completion of this session, the participant should be able to: COMP, • Diagnose restless legs syndrome in under a minute. • Manage restless legs syndrome using practice guidelines. • Diagnose and treat narcolepsy. • Determine the prognosis of, and treat, REM-sleep behavior disorder. Systemic Lupus Erythematosus: Upon completion of this session, the participant should be able to: GL, EBM, COMP • Describe the varied clinical presentations and manifestations in the course of systemic lupus erythematosus. • Order and interpret laboratory testing used in the diagnosis of systemic lupus erythematosus in accordance with ACR Guidelines. • Monitor and employ treatment options for patients with systemic lupus erythematosus according to EULAR recommendations and evidence-based results from clinical studies. Day 4: Dementia: Upon completion of this session, the participant should be able to: COMP, GL • Evaluate patients with mild cognitive impairment or dementia. • Diagnose the major syndromes associated with common causes of dementia. • Distinguish the conditions that frequently mimic dementia. • Manage major complications of dementia. • Utilize the American Psychiatric Association practice guidelines for management of agitated dementia. Parkinson’s Disease and Essential Tremor: Upon completion of this session, the participant should be able to: COMP, GL • Assess the clinical features of the syndrome of parkinsonism. • Evaluate other important typical features of Parkinson’s disease. • Select treatment options for management of Parkinson’s disease. • Distinguish among common types of tremor and devise a therapeutic plan for a patient with essential tremor using American Academy of Neurology evidence-based guidelines. Scleroderma and Raynaud’s Disease: Upon completion of this session, the participant should be able to: GL, COMP • Specify the clinical manifestations of scleroderma. • Apply the ACR/EULAR classification criteria for systemic sclerosis. • Utilize treatment available for symptomatic manifestations as per the current EULAR recommendations. • Apply the diagnostic work-up and treatment of Raynaud’s Phenomenon. Crystal Arthritis: Upon completion of this session, the participant should be able to: • Describe the main clinical features associated with Crystal Arthritis • Gain insight into the pathophysiology of Crystal Arthritis • Discuss treatment modalities for Crystal Arthritis Spasticity, Ataxia, and Gait Disorders: Upon completion of this session, the participant should be able to: COMP • Detect the major clinical features of spasticity. • Institute a diagnostic investigation of cervical spondylosis. • Assess ataxia and the other major clinical features of cerebellar dysfunction. • Evaluate different types of gait disorders.

Pediatric Emergency Medicine: Emergent and Urgent Challenges is organized by American Medical Seminars (AMS), Inc. and will be held from Feb 08 - 11, 2021 at The Westin Sarasota, Sarasota, Florida, United States of America. Accreditation: • 20 AMA PRA Category 1 Credits™ Additional details will be posted as soon as information is available.

Emergency Medicine: An Evidence-Based Approach to Adult Care is organized by American Medical Seminars (AMS), Inc. and will be held from Feb 15 - 18, 2021 at The Westin Sarasota, Sarasota, Florida, United States of America. Accreditation: • 20 AMA PRA Category 1 Credits™ Additional details will be posted as soon as information is available.

Internal Medicine: Pulmonary, Critical Care, Rheumatology, Endocrinology - A Review and Update is organized by American Medical Seminars (AMS), Inc. and will be held from Feb 22 - 25, 2021 at The Westin Sarasota, Sarasota, Florida, United States of America. Accreditation: • 20 AMA PRA Category 1 Credits™ Additional details will be posted as soon as information is available.

Urgent Care: A Comprehensive Approach to Common Challenges is organized by American Medical Seminars (AMS), Inc. and will be held from Mar 01 - 04, 2021 at The Westin Sarasota, Sarasota, Florida, United States of America. Accreditation: • 20 AMA PRA Category 1 Credits™ Additional details will be posted as soon as information is available.